Skip to main content
Fig. 2 | Clinical Proteomics

Fig. 2

From: Quantitative proteomics reveals protein dysregulation during T cell activation in multiple sclerosis patients compared to healthy controls

Fig. 2

Flow cytometry characterization of CD4+ T cells from MS patients (MS) and healthy controls (HC). Proportions of (A) CD69+ and (B) viable CD4+ T cells in unstimulated and stimulated (anti-CD3/CD28 antibody stimulation) samples. Mean and standard deviation are shown, Mann Whitney U test showed no significant differences across groups (MS vs HC). MS  multiple sclerosis, HC  healthy controls

Back to article page

Clinical Proteomics

ISSN: 1559-0275